Due Diligence: What’s Now and What’s Next
Strong due diligence requires the right subject matter experts, strong processes, proper data and knowledge management. Yet while the fundamentals remain, due diligence teams are increasingly challenged to respond to new trends, embrace new technologies, and accelerate their reporting.
Mike Myers, Associate Vice President, LRL – Due Diligence at Eli Lilly & Company, and William Vickery, Due Diligence Director at Servier, join Inova to explore best practices in biopharma due diligence in 2023. From today’s post-pandemic praxes to emerging trends such as assessing carbon emissions and the impact of artificial intelligence, and the differences between due diligence for licensing and acquisitions, Myers and Vickery will share their decades of experience in biopharma partnering in this exclusive Inova webinar.
Please complete the form below
All fields marked with a * are required.
personal data by Inova as detailed in the Privacy Statement.